Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by H Tamai
Treatment of Relapsed Acute Myeloid Leukemia With MLL/AF6 Fusion After Allogeneic Hematopoietic Stem Cell Transplantation With Gemtuzumab Ozogamicin With a Long Interval Followed by Donor Lymphocyte Infusion
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Related publications
Molecular Remission Induced by Gemtuzumab Ozogamicin Associated With Donor Lymphocyte Infusions in T(4;11) Acute Lymphoblastic Leukemia Relapsed After Transplantation
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
Phase I Study of Azacitidine Following Donor Lymphocyte Infusion for Relapsed Acute Myeloid Leukemia Post Allogeneic Stem Cell Transplantation
Leukemia Research
Cancer Research
Oncology
Hematology
Association of Second Allogeneic Hematopoietic Cell Transplant vs Donor Lymphocyte Infusion With Overall Survival in Patients With Acute Myeloid Leukemia Relapse
JAMA Oncology
Cancer Research
Oncology
Extramedullary Relapse of Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
Transplantation
Hematology
Impacts of Post-Transplantation Cyclophosphamide Treatment After Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemia
Scientific Reports
Multidisciplinary
Antibody-Based Therapy of Acute Myeloid Leukemia With Gemtuzumab Ozogamicin
Frontiers in Bioscience - Landmark
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia Harboring T(7;11)(p15;p15)
Blood
Biochemistry
Immunology
Cell Biology
Hematology
Late Ovarian and Intestinal Extramedullary Relapse of Acute Myeloid Leukemia With Inv 16 After Allogeneic Hematopoietic Stem Cell Transplantation
Annals of Hematology & Oncology
Preliminary Results of the Safety of Immunotherapy With Gemtuzumab Ozogamicin Following Reduced Intensity Allogeneic Stem Cell Transplant in Children With CD33+ Acute Myeloid Leukemia
Clinical Cancer Research
Cancer Research
Oncology
